GSA Capital Partners’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,310	Closed	-$242K	–	1724
2024 Q4	$242K	Buy	+1,310	New	+$252K	0.02%	1324
2020 Q1	–	Sell	-16,572	Closed	-$2.53M	–	1134
2019 Q4	$2.53M	Sell	16,572 -2,451	-13%	-$339K	0.29%	13
2019 Q3	$2.52M	Buy	19,023 +6,297	+49%	+$844K	0.34%	8
2019 Q2	$1.81M	Sell	12,726 -3,774	-23%	-$512K	0.2%	58
2019 Q1	$2.4M	Buy	16,500 +659	+4%	+$86.6K	0.24%	46
2018 Q4	$1.79M	Buy	15,841 +3,564	+29%	+$446K	0.21%	69
2018 Q3	$1.65M	Sell	12,277 -5,974	-33%	-$737K	0.09%	351
2018 Q2	$2.05M	Sell	18,251 -14,503	-44%	-$1.57M	0.1%	265
2018 Q1	$3.5M	Buy	32,754 +823	+3%	+$88.7K	0.18%	72
2017 Q4	$3.5M	Buy	31,931 +8,747	+38%	+$952K	0.21%	55
2017 Q3	$2.5M	Buy	23,184 +10,544	+83%	+$1.08M	0.17%	85
2017 Q2	$1.28M	Sell	12,640 -21,766	-63%	-$2M	0.08%	375
2017 Q1	$3.1M	Sell	34,406 -13,485	-28%	-$1.15M	0.17%	99
2016 Q4	$3.65M	Sell	47,891 -2,770	-5%	-$210K	0.22%	42
2016 Q3	$4.22M	Sell	50,661 -5,485	-10%	-$460K	0.23%	35
2016 Q2	$4.63M	Buy	56,146 +1,467	+3%	+$121K	0.26%	22
2016 Q1	$4.15M	Sell	54,679 -4,682	-8%	-$347K	0.26%	20
2015 Q4	$4.77M	Buy	59,361 +1,209	+2%	+$87.2K	0.23%	27
2015 Q3	$3.69M	Sell	58,152 -30,126	-34%	-$2.16M	0.18%	75
2015 Q2	$6.21M	Buy	88,278 +42,523	+93%	+$3.15M	0.24%	35
2015 Q1	$3.63M	Buy	45,755 +2,842	+7%	+$210K	0.14%	108
2014 Q4	$2.73M	Buy	42,913 +15,447	+56%	+$968K	0.19%	67
2014 Q3	$1.64M	Sell	27,466 -13,531	-33%	-$774K	0.09%	254
2014 Q2	$2.19M	Buy	40,997 +20,667	+102%	+$1.13M	0.1%	218
2014 Q1	$1.23M	Sell	20,330 -7,178	-26%	-$418K	0.09%	241
2013 Q4	$1.46M	Sell	27,508 -12,486	-31%	-$627K	0.12%	179
2013 Q3	$1.85M	Buy	39,994 +18,601	+87%	+$854K	0.15%	137
2013 Q2	$878K	Buy	+21,393	New	+$917K	0.1%	260